The AHA and several safety-net providers argue that an upcoming mandatory rebate pilot violates administrative law, imposes millions in costs, and threatens patient care in vulnerable communities.
Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.
Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York ...
Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs ...
The American Hospital Association, a Maine hospital group and four nonprofit systems are seeking a temporary restraining ...
340B is a tremendous federal program that ought to be fixed — by the federal government. A state initiative would make things worse. Credit: Getty Images. When something isn't working, we look to our ...
Some hospitals are buying life-saving medications for pennies, then charging low-income patients, including many with disabilities, hundreds of dollars for these drugs. They do it every day under a ...
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback